Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut; VA CT Healthcare System, West Haven, Connecticut; Department of Anthropology, University of Toronto, Mississauga, Ontario, Canada; Biostatistics Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut; VA CT Healthcare System, West Haven, Connecticut.
Biol Psychiatry. 2023 Feb 1;93(3):243-252. doi: 10.1016/j.biopsych.2022.07.019. Epub 2022 Aug 5.
The presentation, etiology, and relative risk of psychiatric disorders are strongly influenced by biological sex. Neuroticism is a transdiagnostic feature of psychiatric disorders displaying prominent sex differences. We performed genome-wide association studies of neuroticism separately in males and females to identify sex-specific genetic and transcriptomic profiles.
Neuroticism scores were derived from the Eysenck Personality Inventory Neuroticism scale. Genome-wide association studies were performed in 145,669 females and 129,229 males from the UK Biobank considering autosomal and X chromosomal variation. Two-sided z tests were used to test for sex-specific effects of discovered loci, genetic correlates (n = 673 traits), tissue and gene transcriptomic profiles, and polygenic associations across health outcomes in the Vanderbilt University Biobank (39,692 females and 31,268 males).
The single nucleotide polymorphism heritability of neuroticism was not statistically different between males (h = 10.6%) and females (h = 11.85%). Four female-specific (rs10736549-CNTN5, rs6507056-ASXL3, rs2087182-MMS22L, and rs72995548-HSPB2) and 2 male-specific (rs10507274-MED13L and rs7984597) neuroticism risk loci reached genome-wide significance. Male- and female-specific neuroticism polygenic scores were most significantly associated with mood disorders (males: odds ratio = 1.11, p = 1.40 × 10; females: odds ratio = 1.14, p = 6.05 × 10). They also associated with sex-specific laboratory measurements related to erythrocyte count, distribution, and hemoglobin concentration. Gene expression variation in the pituitary was enriched for neuroticism loci in males (male: b = 0.026, p = .002), and genetically regulated transcriptomic changes highlighted the effect of SHISHA9, TEX26, and NCOA6.
Through a comprehensive assessment of genetic risk for neuroticism and the associated biological processes, this study identified several molecular pathways that can partially explain the known sex differences in neurotic symptoms and their psychiatric comorbidities.
精神障碍的表现、病因和相对风险受到生物性别强烈影响。神经质是精神障碍的一种跨诊断特征,表现出明显的性别差异。我们分别在男性和女性中进行了神经质的全基因组关联研究,以确定性别特异性的遗传和转录组特征。
神经质评分源自艾森克人格问卷神经质量表。在英国生物库中,对 145669 名女性和 129229 名男性进行了全基因组关联研究,考虑了常染色体和 X 染色体变异。使用双尾 z 检验来检验发现的位点、遗传相关性(n=673 个特征)、组织和基因转录组特征以及范德比尔特大学生物库中健康结果的多基因关联(39692 名女性和 31268 名男性)中的性别特异性效应。
神经质的单核苷酸多态性遗传率在男性(h=10.6%)和女性(h=11.85%)之间没有统计学差异。四个女性特异性(rs10736549-CNTN5、rs6507056-ASXL3、rs2087182-MMS22L 和 rs72995548-HSPB2)和两个男性特异性(rs10507274-MED13L 和 rs7984597)神经质风险位点达到了全基因组显著水平。男性和女性特异性的神经质多基因评分与情绪障碍的相关性最显著(男性:比值比=1.11,p=1.40×10;女性:比值比=1.14,p=6.05×10)。它们还与与红细胞计数、分布和血红蛋白浓度相关的实验室测量的性别特异性有关。男性垂体中的基因表达变化在神经质基因座中富集(男性:b=0.026,p=0.002),而遗传调节的转录组变化突出了 SHISHA9、TEX26 和 NCOA6 的作用。
通过对神经质遗传风险及其相关生物学过程的综合评估,本研究确定了几个分子途径,这些途径可以部分解释神经质症状及其精神共病已知的性别差异。